Suresnes, October 16th, 2024 – Servier, an independent global pharmaceutical group, announces that it has partnered with Klineo, an innovative digital technology start-up, to improve access to and knowledge of ongoing clinical trials for patients. This partnership is an integral part of Servier’s digital health strategy, reflected in WeHealth by Servier*.
Access to information on clinical trials can be complex and difficult for rare disease patients and their doctors. Klineo’s digital platform provides an accessible and intuitive tool that enables patients and/or referring specialists to quickly find suitable clinical trials in France. By means of a dedicated digital interface, patients can be informed in real time of therapeutic opportunities corresponding to their profile.
The aim of this partnership is to make information on currently available clinical trials more accessible, particularly in rare cancers where patient recruitment can pose a major challenge.
“Through this initial venture with Klineo, we’ll be able to validate the suitability of this particular method and consider expanding it to a larger number of studies, covering more extensive geographical areas outside France.”
Sophie Garnault, Director of Oncology Clinical Operations Servier
“Our collaboration with Klineo is a clear reflection of our commitment to putting patients at the heart of our clinical strategy and using the power of technology to deliver effective solutions and drive patient recruitment. And by making information on clinical studies more readily available, we’re helping to reduce inequalities in access to therapeutic innovations.”
Magali Moutte, Project Director for Servier’s WeHealth Digital Factory
At this point, only Servier’s oncology clinical trials in France will be available on the platform. Once the initial feedback has been evaluated, the Group will consider rolling out the service to other countries.
“Our partnership with Servier will allow us to benefit from the clinical research expertise of its employees and directly support our mission to provide all patients with access to therapeutic innovations.”
Thomas Peyresblanques, President of Klineo
*WeHealth by Servier is the expression of Servier’s digital health strategy, aimed at two key industry players: start-ups and incubators. It is part of a dynamic, open innovation ecosystem that focuses on developing various partnerships (co-development, licensing, strategic partnerships), drawing on the expertise of our teams around the world.